ERC Starting Grant 2020-2025

Synthetic T-rEX
ERC Starting Grant 2020-2025

The project combines biotechnology with medicine to enhance immunotherapies based on the use of genetically modified T cells, the so called CAR-T cells. CAR-T cells, which are currently used for the treatment of blood cancers and which have also being tested for solid tumors, in some cases may lose their effectiveness, becoming exhausted.